Data involving three studies with 360 bladder cancer patients showed that CD44 expression was significantly correlated with lymph node metastasis (OR = 4.09, 95% CI = 2.20–7.62, P < 0.001) (Figure 3). This evidence concerns the gene CD44 and urinary bladder carcinoma.